Andrew J. Park
YOU?
Author Swipe
View article: Virtual Reality Campus Navigation Incorporating Inclusion, Diversity, Equity, and Accessibility
Virtual Reality Campus Navigation Incorporating Inclusion, Diversity, Equity, and Accessibility Open
View article: Exploring ‘Potentially Competing’ Studies and RAG Process Design Using a Pivot and its Forward Citation Network
Exploring ‘Potentially Competing’ Studies and RAG Process Design Using a Pivot and its Forward Citation Network Open
View article: New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradication
New perspectives in hepatocellular carcinoma surveillance after hepatitis C virus eradication Open
Achieving a sustained virologic response (SVR) through direct-acting antivirals for hepatitis C virus (HCV) infection significantly reduces the long-term risk of hepatocellular carcinoma (HCC), particularly in patients with advanced fibros…
View article: Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Purpose:PD-L1 is upregulated in glioblastoma and supports immunosuppression. We evaluated PD-L1 blockade with durvalumab among glioblastoma cohorts and investigated potential biomarkers.Patients and Methods:MGMT unmethylated newly diagnose…
View article: Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Data from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Purpose:PD-L1 is upregulated in glioblastoma and supports immunosuppression. We evaluated PD-L1 blockade with durvalumab among glioblastoma cohorts and investigated potential biomarkers.Patients and Methods:MGMT unmethylated newly diagnose…
View article: Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma Open
Supplementary Figure from Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma
View article: Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends Study
Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends Study Open
Purpose Missing data is a key methodological consideration in longitudinal studies of aging. We described missing data challenges and potential methodological solutions using a case example describing five-year frailty state transitions in…
View article: Things We Carry
Things We Carry Open
View article: A microwave method to remotely assess the abdominal fat thickness
A microwave method to remotely assess the abdominal fat thickness Open
We introduce a method to measure the fat thickness by harnessing the physics of destructive interference. At certain frequencies, when the fat thickness equals a quarter wavelength, the amplitude of the reflected wave is minimized due to t…
View article: Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07)
Machine Learning Model to Predict Pseudoprogression Versus Progression in Glioblastoma Using MRI: A Multi-Institutional Study (KROG 18-07) Open
Some patients with glioblastoma show a worsening presentation in imaging after concurrent chemoradiation, even when they receive gross total resection. Previously, we showed the feasibility of a machine learning model to predict pseudoprog…
View article: Noncontrast MRI with advanced diffusion weighted imaging for breast cancer detection in a lactating woman
Noncontrast MRI with advanced diffusion weighted imaging for breast cancer detection in a lactating woman Open
Magnetic resonance imaging (MRI) is used for preoperative evaluation, high-risk screening, and other select indications for breast cancer. However, the interpretation of breast MR images in pregnant and lactating women is complicated by ph…
View article: VARIATION OF THE SHAPE PARAMETER OF K-DISTRIBUTION FOR SEA CLUTTER WITH THE SPATIAL CORRELATION OF SEA SURFACE
VARIATION OF THE SHAPE PARAMETER OF K-DISTRIBUTION FOR SEA CLUTTER WITH THE SPATIAL CORRELATION OF SEA SURFACE Open
View article: Enhanced steering ability of the distal end of a magnetic catheter by utilizing magnets with optimized magnetization direction
Enhanced steering ability of the distal end of a magnetic catheter by utilizing magnets with optimized magnetization direction Open
We developed a magnetic catheter with enhanced steering ability of the distal end by utilizing magnets with optimized magnetization directions. The proposed magnetic catheter is composed of a flexible tube and three-ring magnets that enabl…
View article: Selective separating and assembling motion control for delivery and retrieval of an untethered magnetic robot in human blood vessels
Selective separating and assembling motion control for delivery and retrieval of an untethered magnetic robot in human blood vessels Open
We developed an integrated magnetic robot (IMR) that can selectively separate and assemble tethered and untethered magnetic robots. The proposed IMR is composed of a flexible-legged untethered magnetic robot (FLUMR) and a delivery catheter…
View article: Image-based feedback control of a magnetic catheter to enhance the path-following capability of the position and orientation at its distal part
Image-based feedback control of a magnetic catheter to enhance the path-following capability of the position and orientation at its distal part Open
We have proposed a novel image-based feedback control method to enhance the path-following capability for position and orientation of a magnetic catheter at its distal part. The proposed control method uses only a navigation status of the …
View article: Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons:
Preexposure Prophylaxis for Human Immunodeficiency Virus Infection for Men Who Have Sex with Men and Transgender Persons: Open
View article: Leveraging the electronic health record to improve dermatologic care delivery: The importance of finding structure in data
Leveraging the electronic health record to improve dermatologic care delivery: The importance of finding structure in data Open
View article: Generation of virtual lung single‐photon emission computed tomography/CT fusion images for functional avoidance radiotherapy planning using machine learning algorithms
Generation of virtual lung single‐photon emission computed tomography/CT fusion images for functional avoidance radiotherapy planning using machine learning algorithms Open
Introduction Functional image‐guided radiotherapy (RT) planning for normal lung avoidance has recently been introduced. Single‐photon emission computed tomography (SPECT)/CT can help identify the functional areas of lungs, but it is associ…
View article: Paucity of Lesbian, Gay, Bisexual, and Transgender Health-Related Content in the Basic Dermatology Curriculum
Paucity of Lesbian, Gay, Bisexual, and Transgender Health-Related Content in the Basic Dermatology Curriculum Open
This cross-sectional study examines the extent to which an online dermatology curriculum for medical students incorporated lesbian, gay, bisexual, and transgender health-related content.